US · Healthcare

Allergy Therapeutics plc (AGYTF)

Drug Manufacturers - Specialty & Generic

Allergy Therapeutics plc (AGYTF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for AGYTF

P/E ratio

18.00

Allergy Therapeutics plc (AGYTF) — FAQ

What is AGYTF's P/E ratio?

The price-to-earnings (P/E) ratio for Allergy Therapeutics plc (AGYTF) is 18.00 (data as of 2026-05-23).

Does Allergy Therapeutics plc pay a dividend?

Dividend yield is not available in the current snapshot for Allergy Therapeutics plc (AGYTF). Check the MyAverix Finance app for the latest dividend data.

What sector is Allergy Therapeutics plc in?

Allergy Therapeutics plc (AGYTF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is AGYTF listed on?

AGYTF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)